AzTrials
AzTrials

Necrotic PulpRCTNCT03083015

Pulp Revascularization Versus MTA Apexification

A study testing revascularization and Apexification in people with Necrotic Pulp, run by Enas Ebrahim Sayed.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study compared the efficiency of pulp revascularization and MTA apexification in the treatment of patients with necrotic immature anterior teeth. Read more about this study

Who is it for?
Ages 7 to 16 yearsHealthy volunteers can take part
Conditions the study is for
Necrotic Pulp
What is being tested?
revascularization and Apexification
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
66 participants
Where
No sites listed yet
Study dates
6 Dec 2012to 2 Dec 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 7 to 16 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Medically-free patients having immature necrotic anterior teeth (with or without apical periodontitis/abscess) even with previous intervention.

Who cannot join

  • History of allergy to any of the antibiotics in the tri-mix used in the study
  • Patients with systemic diseases e.g. Diabetes mellitus, bleeding disorders,…
  • Psychological disturbance
  • External / internal root resorption or cystic lesion.

About this study

Official title: A Comparative Study Between Pulp Revascularization and MTA Apexification in Necrotic Immature Anterior Teeth, A Randomized Controlled Trial

This study compared the efficiency of pulp revascularization and MTA apexification in the treatment of patients with necrotic immature anterior teeth.

Read the detailed description

the participants with 66 anterior necrotic immature teeth were randomly assigned into two equal groups with 33 teeth per each, according to regeneration and MTA apexification. At the first visit, all teeth were accessed and irrigated with NaOCl then a TAP was applied as intra-appointment intracanal medication. At the second visit, after removal of the medication with the irrigation, bleeding was initiated into the canal and isolated by the MTA in the orifice in the regeneration group. While in the Apexification group, the MTA was packed apically and all teeth were finally restored with resin composite restorations. The patients were recalled after 1, 3, 6, and 9 months for clinical and radiographic follow up.

Conditions
Necrotic Pulp
Being tested
revascularization, Apexification
Keywords
regeneration, MTA apexification and TAP, revascularization
Medical subject headings
Dental Pulp Necrosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • revascularizationProcedure or surgery

    Also called regeneration

    a sterile sharp needle was used to irritate the apical tissue until bleeding occurred apically in the root canal space so as to create a biological scaffold for the regenerative process

  • ApexificationProcedure or surgery

    a 3-5 mm thickness of MTA using a hand plugger and was verified radiographically.

Study groups in NCT03083015
Study groupRoleWhat they receive
RevascularizationExperimentalBlood clot initiation and grey MTA ( Mineral Tri-oxide Aggregate) cervically compacted.
Receives: Procedure: revascularization
ApexficationActive comparatorApexification using grey MTA apically compacted without mechanical preparation.
Receives: Procedure: Apexification

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain intensity measures

    self reported pain intesity at 4, 12, 24, and 48 hours.(0= no pain and 100=worst pain) with a scale from 0 to 100 after the two visits.

    Measured: 2 days

Secondary outcomes (4)
  1. Resolution of periapical pathosis

    Radiographically: by comparing radiolucencies in 9 months postoperative radiograph to the baseline radiograph.

    Measured: 9 months

  2. Amount of radiographic increase in root length:

    Root length was measured as a straight line from the cement-enamel junction to the radiographic apex of the tooth in millimeters = (9months follow up length - baseline length)

    Measured: baseline and 9 months

  3. Amount of radiographic increase in the root dentinal wall thickness:

    Dentin thickness was measured by =root thickness-pulp space and compared to the baseline radiograph measurements.

    Measured: baseline and 9 months

  4. Decrease of apical diameter:

    the diameter of the apical foramen was measured in millimeters and compared to the baseline radiograph measurements

    Measured: baseline and 9 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Mar 2017
  2. Study start6 Dec 2012
  3. Primary completion2 Dec 2015
  4. Study completion2 Dec 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
participants are allocated at random to receive one of two interventions according to the research plan. In RCT the outcomes are measured, so it is considered a quantitative study . This trial conforms to the Consolidated Standard of Reporting Trials (CONSORT)statement.
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
66 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03083015
Sponsor's protocol ID
Revas1
Other IDs
cebd
Acronym
RCT
Status last verified
Mar 2017
First submitted
7 Mar 2017
Last updated
21 Mar 2017
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Saoud TM, Zaazou A, Nabil A, Moussa S, Lin LM, Gibbs JL. Clinical and radiographic outcomes of traumatized immature permanent necrotic teeth after revascularization/revitalization therapy. J Endod. 2014 Dec;40(12):1946-52. doi: 10.1016/j.joen.2014.08.023. Epub 2014 Oct 16.

    PubMed 25443280
  • Alobaid AS, Cortes LM, Lo J, Nguyen TT, Albert J, Abu-Melha AS, Lin LM, Gibbs JL. Radiographic and clinical outcomes of the treatment of immature permanent teeth by revascularization or apexification: a pilot retrospective cohort study. J Endod. 2014 Aug;40(8):1063-70. doi: 10.1016/j.joen.2014.02.016. Epub 2014 Jun 13.

    PubMed 25069909

Questions about this trial

What is this clinical trial studying?

A study testing revascularization and Apexification in people with Necrotic Pulp, run by Enas Ebrahim Sayed.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Mar 2017. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain intensity measures (time frame: 2 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03083015, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Mar 2017.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in